Tag Archives: Drug

Fueled by COVID drug manufacturing revenues, CDMO Jubilant HollisterStier invests in upgrades, expansion

Since the onset of the coronavirus pandemic, Jubilant HollisterStier has been busy churning out COVID-19 treatments and more recently vaccines. Now it’s turning those revenues from the increased business into an investment in the future. The Spokane, Washington-based CDMO revealed a $ 92 million expansion plan this week that includes a high-speed injectable fill line with… Read More »

The UK’s National Health Service just approved a drug that costs nearly $2.5 million a dose

Kate Cardente holds her then 3-month-old daughter, Ainsley, as she undergoes a gene therapy for Spinal Muscular Atrophy (SMA). SMA is a disease that is the primary genetic cause of death in babies. Ainsley is getting a one-time infusion of Zolgensma. Baltimore Sun | Tribune News Service | Getty Images LONDON — A drug that… Read More »

Transparency by drug companies, scrutiny by journalists, vital in vaccine news

Pfizer’s chairman and CEO proclaimed in a Pfizer company news release: “Today is a great day for science and humanity.” In that PR news release – but only in that format – Pfizer announced early results of “a vaccine efficacy rate above 90%, at 7 days after the second dose.” That’s about all we know… Read More »

It has come to this: ignore vaccines-in-animals drug industry PR & news

A long-haired male golden hamster (via Wikipedia & Creative Commons) Earlier this week, a powerful opinion piece, “It Has Come To This:  Ignore the CDC,”  co-authored by former National Institutes of Health director Harold Varmus,  was published in the New York Times. That’s on the science side. On the PR and journalism side, it has… Read More »

Watch live: Pharma executives testify at House hearing on drug pricing

[embedded content] [The stream is slated to start at 10 a.m. ET. Please refresh the page if you do not see a player above at that time.] The U.S. House of Representatives Oversight and Reform Committee is holding a hearing Wednesday with current and former executives of three major drug companies on the high cost… Read More »

Stanford Medicine to test drug on less serious COVID-19 cases – SF Gate

Medical researchers perform serology — testing blood samples to find out whether someone already had and recovered from COVID-19 — in Stanford University’s Clinical Virology Lab. Medical researchers perform serology — testing blood samples to find out whether someone already had and recovered from COVID-19 — in Stanford University’s Clinical Virology Lab. Photo: Steve Fisch/Stanford… Read More »

What drug can replace cymbalta

Lexchin It definitely slowed down my metabolism. For this reason, doctors monitor people carefully during the first 4 months of treatment for mood changes and other adverse effects. In this review we decided to focus on treatment response because it is one of the main goals for the treatment of major depressive disorder. Before using… Read More »